BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26709220)

  • 21. Ischemic heart disease and rheumatoid arthritis: Do inflammatory cytokines have a role?
    El Bakry SA; Fayez D; Morad CS; Abdel-Salam AM; Abdel-Salam Z; ElKabarity RH; El Dakrony AHM
    Cytokine; 2017 Aug; 96():228-233. PubMed ID: 28477538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of T helper 17 cells in the pathogenesis of systemic lupus erythematosus.
    Abou Ghanima AT; Elolemy GG; Ganeb SS; Abo Elazem AA; Abdelgawad ER
    Egypt J Immunol; 2012; 19(2):25-33. PubMed ID: 23885404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis.
    Melis L; Vandooren B; Kruithof E; Jacques P; De Vos M; Mielants H; Verbruggen G; De Keyser F; Elewaut D
    Ann Rheum Dis; 2010 Mar; 69(3):618-23. PubMed ID: 19196728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced concentrations of interleukin 16 are associated with joint destruction in patients with rheumatoid arthritis.
    Lard LR; Roep BO; Toes RE; Huizinga TW
    J Rheumatol; 2004 Jan; 31(1):35-9. PubMed ID: 14705216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brief report: inhibition of interleukin-6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis.
    Samson M; Audia S; Janikashvili N; Ciudad M; Trad M; Fraszczak J; Ornetti P; Maillefert JF; Miossec P; Bonnotte B
    Arthritis Rheum; 2012 Aug; 64(8):2499-503. PubMed ID: 22488116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum cytokine and periodontal profiles in relation to disease activity of rheumatoid arthritis in Japanese adults.
    Kobayashi T; Murasawa A; Komatsu Y; Yokoyama T; Ishida K; Abe A; Yamamoto K; Yoshie H
    J Periodontol; 2010 May; 81(5):650-7. PubMed ID: 20429644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: results from the ESPOIR cohort.
    Gottenberg JE; Dayer JM; Lukas C; Ducot B; Chiocchia G; Cantagrel A; Saraux A; Roux-Lombard P; Mariette X
    Ann Rheum Dis; 2012 Jul; 71(7):1243-8. PubMed ID: 22532637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proinflammatory cytokine profiles of patients with elderly-onset rheumatoid arthritis: a comparison with younger-onset disease.
    Chen DY; Hsieh TY; Chen YM; Hsieh CW; Lan JL; Lin FJ
    Gerontology; 2009; 55(3):250-8. PubMed ID: 18849599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leucine-rich α2 -glycoprotein as a potential biomarker for joint inflammation during anti-interleukin-6 biologic therapy in rheumatoid arthritis.
    Fujimoto M; Serada S; Suzuki K; Nishikawa A; Ogata A; Nanki T; Hattori K; Kohsaka H; Miyasaka N; Takeuchi T; Naka T
    Arthritis Rheumatol; 2015 May; 67(8):2056-60. PubMed ID: 25917892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
    Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
    Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin 10 (IL-10), not IL-4 or interferon-gamma production, correlates with progression of joint destruction in rheumatoid arthritis.
    Verhoef CM; van Roon JA; Vianen ME; Bijlsma JW; Lafeber FP
    J Rheumatol; 2001 Sep; 28(9):1960-6. PubMed ID: 11550960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of STAT-3 in rheumatoid synovial T cells suppresses Th17 differentiation and increases the proportion of Treg cells.
    Ju JH; Heo YJ; Cho ML; Jhun JY; Park JS; Lee SY; Oh HJ; Moon SJ; Kwok SK; Park KS; Park SH; Kim HY
    Arthritis Rheum; 2012 Nov; 64(11):3543-52. PubMed ID: 22736176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early diagnostic and prognostic values of anti-cyclic citrullinated peptide antibody and cartilage oligomeric matrix protein in rheumatoid arthritis.
    Algergawy SA; Abd El-Sabour M; Osman AS; Emam SM; Elham N
    Egypt J Immunol; 2013; 20(2):11-20. PubMed ID: 24617043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis.
    Leipe J; Schramm MA; Grunke M; Baeuerle M; Dechant C; Nigg AP; Witt MN; Vielhauer V; Reindl CS; Schulze-Koops H; Skapenko A
    Ann Rheum Dis; 2011 Aug; 70(8):1453-7. PubMed ID: 21593004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways.
    Liu C; Jiang J; Gao L; Wang X; Hu X; Wu M; Wu J; Xu T; Shi Q; Zhang X
    Arthritis Res Ther; 2015 Nov; 17():340. PubMed ID: 26608464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of T helper 17 cells of synovial fluid in rheumatoid arthritis].
    Lin H; Zhou YL; Li J; Li YJ; Zhao Y; Yan B; Liu Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 44(6):907-10. PubMed ID: 24490499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A distinct multicytokine profile is associated with anti-cyclical citrullinated peptide antibodies in patients with early untreated inflammatory arthritis.
    Hitchon CA; Alex P; Erdile LB; Frank MB; Dozmorov I; Tang Y; Wong K; Centola M; El-Gabalawy HS
    J Rheumatol; 2004 Dec; 31(12):2336-46. PubMed ID: 15570632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study).
    Heimans L; Akdemir G; Boer KV; Goekoop-Ruiterman YP; Molenaar ET; van Groenendael JH; Peeters AJ; Steup-Beekman GM; Lard LR; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF
    Arthritis Res Ther; 2016 Jan; 18():23. PubMed ID: 26794605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarkers in Remission According to Different Criteria in Patients with Rheumatoid Arthritis.
    Yilmaz-Oner S; Ozen G; Can M; Atagunduz P; Direskeneli H; Inanc N
    J Rheumatol; 2015 Nov; 42(11):2066-70. PubMed ID: 26472417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.